Patent News for Wednesday 1st May 2024

1. FTC IDs 300 'Junk Patents' Among Drugmakers | HealthLeaders Media

FTC IDs 300+ 'Junk Patents' Among Drugmakers · Topics · The warning letters don't specify how the drugmakers are flouting patent regulations, or what ...

2. FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic

The Federal Trade Commission said it is challenging hundreds of alleged "junk" patents held by pharmaceutical companies for 20 brand-name drugs, ...

3. FTC targets Novo's Ozempic among 300-plus 'junk' patents - Fierce Pharma

The U.S. Federal Trade Commission (FTC) is not done with its crackdown on what it views as improper listing of patents with the FDA.

4. FTC Targets 'Junk' Patents Including Novo's Ozempic, GSK's Trelegy Ellipta and Other Drugs

In a bid to improve competition in the industry, the U.S. Federal Trade Commission is challenging the patents of 20 different pharmaceutical ...

5. Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US ...

... patents covering p38 MAP kinase inhibitors for influenza treatment and hypercytokinemia. Additional patents have been filed, particularly focusing ...

6. What We're Reading: FTC Challenges Drugmaker Patents; Testing Ground Beef for Bird Flu

The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department ...

7. FTC cracks down on drug patents - Becker's Hospital Review

The agency is disputing the accuracy of more than 300 patent listings in the Orange Book, an FDA document of patents for brand name products. The FTC ...

8. US trade panel to probe GoPro's claims that Chinese firm violated its patents | Reuters

... Inc that its camera and camera systems patents were violated by a Chinese company importing similar products into the U.S..

9. FTC Challenges 'Bogus' Patents on Ozempic and Other Drugs | MedPage Today

Patents block competition and inflate prescription drug cost, says FTC chair.

10. FTC targets 'junk patents' on Ozempic, other top drugs - BioPharma Dive

The Federal Trade Commission is challenging more than 300 patents filed with the Food and Drug Administration to protect market exclusivity for top- ...

11. GSK pushes back on FTC 'junk patents' claim as it raises profit outlook - Financial Times

After patents expire, generic drugmakers can create products based on the original, enabling lower prices through competition. But pharmaceutical ...

12. FTC fighting 'junk' patents, Pfizer plans direct-to-consumer push - STAT News

Pharmalittle: We're reading about FTC fighting 'junk' patents, Pfizer direct-to-consumer plans, and more. Ed Silverman. By Ed Silverman May 1, 2024.

13. PayRange Agrees to License Tech Patents to WASH - American Coin-Op

The agreement licenses PayRange's patents for use with the WASH-Connect Mobile Payment App and will continue for the term of PayRange's patents.

14. US Challenges 'Bogus' Patents on Ozempic and Other Drugs in Effort to Spur ... - USNews.com

WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic, ...

15. FTC Weighs In on Orange Book Listing of Drug-Device Patents - Lexology

Amneal"), stating that the court should grant Amneal's motion for judgment on the pleadings to compel Teva to de-list certain patents in the U.S. ...

16. US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition

By MATTHEW PERRONE AP Health Writer. WASHINGTON (AP) — The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the ...

17. FTC Challenges Patents on 20 Brand-Name Drugs as Chair Accuses Them of Inflating ...

The Federal Trade Commission challenges patents on 20 brand-name drugs to spur competition, including the blockbuster weight-loss drug Ozempic.

18. US to probe GoPro claims Chinese firm violated its patents - CNA

WASHINGTON :The U.S. International Trade Commission is launching a probe into GoPro claims that patents for its cameras, systems and accessories ...

19. PTAB Issues Final Written Decisions Finding Claims of Recombinant Lentiviral Vector Patents Valid

On April 22, 2024, the PTAB issued final written decisions in IPR2023-00070 and IPR2023-00074, filed by Bluebird Bio on two patents related to ...

20. US to probe GoPro claims Chinese firm violated its patents - Yahoo Finance

WASHINGTON (Reuters) -The U.S. International Trade Commission is launching a probe into GoPro claims that patents for its cameras, ...

21. Mathilde Do Chi, Expert on Food Law, Part 4: Why Patents Are Not the Safest Way to Protect ...

In this fourth installment of this special series, Mathilde discusses the limitations and dangers around patents in food innovation.

22. USPTO announces National Strategy for Inclusive Innovation

... patents are women. At the same time, a Harvard University study revealed that white Americans are three times more likely to invent than Black ...

23. FTC steps up campaign on junk patents with warning letters - Pharmaphorum

FTC sends more warnings to pharma companies over 'junk' patents to protect drugs from generic competition, including Novo Nordisk's Ozempic.

24. NEWS: Sanders Responds to FTC's Efforts to Target 'Junk' Ozempic Patents

Let me commend the Federal Trade Commission, under the leadership of Chair Lina Khan, for taking bold action today against the bogus patents Novo ...

25. Boehringer Ingelheim Accused of Using Expired Patents to Con... - Law.com

... patents to delay competition between brand name and generic inhalers. The lawsuit, filed Monday in Connecticut federal court, was followed Tuesday ...